1. A critical review of graphics for subgroup analyses in clinical trials. (25th March 2020) Authors: Ballarini, Nicolás M.; Chiu, Yi‐Da; König, Franz; Posch, Martin; Jaki, Thomas Journal: Pharmaceutical statistics Issue: Volume 19:Number 5(2020) Page Start: 541 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
2. A multiple comparison procedure for dose‐finding trials with subpopulations. Issue 1 (23rd September 2019) Authors: Thomas, Marius; Bornkamp, Björn; Posch, Martin; König, Franz Journal: Biometrical journal Issue: Volume 62:Issue 1(2020:Jan.) Page Start: 53 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
3. Adaptive designs for subpopulation analysis optimizing utility functions. Issue 1 (14th November 2014) Authors: Graf, Alexandra C.; Posch, Martin; Koenig, Franz Journal: Biometrical journal Issue: Volume 57:Issue 1(2015:Jan.) Page Start: 76 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
4. Adaptive graph‐based multiple testing procedures. (16th October 2014) Authors: Klinglmueller, Florian; Posch, Martin; Koenig, Franz Journal: Pharmaceutical statistics Issue: Volume 13:Number 6(2014:Nov./Dec.) Page Start: 345 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
5. Approaches to sample size calculation for clinical trials in rare diseases. (10th January 2018) Authors: Miller, Frank; Zohar, Sarah; Stallard, Nigel; Madan, Jason; Posch, Martin; Hee, Siew Wan; Pearce, Michael; Vågerö, Mårten; Day, Simon Journal: Pharmaceutical statistics Issue: Volume 17:Number 3(2018) Page Start: 214 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
6. Are p-values Useful to Judge the Evidence Against the Null Hypotheses in Complex Clinical Trials? A Comment on "The Role of p-values in Judging the Strength of Evidence and Realistic Replication Expectations". (23rd December 2020) Authors: Posch, Martin; König, Franz Journal: Statistics in biopharmaceutical research Issue: Volume 13:Number 1(2021) Page Start: 43 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
7. Assessment of tumour-agnostic therapies in basket trials. Issue 1 (January 2022) Authors: Collignon, Olivier; Posch, Martin; Schiel, Anja Journal: Lancet oncology Issue: Volume 23:Issue 1(2022) Page Start: e8 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
8. Association of Acute Kidney Injury Receiving Kidney Replacement Therapy With Prognosis of Critically Ill Patients With and Without Cancer: A Retrospective Study. Issue 11 (24th June 2021) Authors: Druml, Wilfred; Zajic, Paul; Schellongowski, Peter; Fellinger, Tobias; Metnitz, Barbara; Posch, Martin; Metnitz, Philipp G. H. Journal: Critical care medicine Issue: Volume 49:Issue 11(2021) Page Start: 1932 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
9. Association of Acute Kidney Injury Receiving Kidney Replacement Therapy With Prognosis of Critically Ill Patients With and Without Cancer: A Retrospective Study. Issue 11 (November 2021) Authors: Druml, Wilfred; Zajic, Paul; Schellongowski, Peter; Fellinger, Tobias; Metnitz, Barbara; Posch, Martin; Metnitz, Philipp G. H. Journal: Critical care medicine Issue: Volume 49:Issue 11(2021) Page Start: Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
10. Author's reply. Issue 2 (16th January 2013) Authors: Bretz, Frank; Posch, Martin; Glimm, Ekkehard; Klinglmueller, Florian; Maurer, Willi; Rohmeyer, Kornelius Journal: Biometrical journal Issue: Volume 55:Issue 2(2013:Mar.) Page Start: 266 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗